TrivarX Limited
MDBIF
$0.0244
$0.02231,061.91%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 684.50K | 347.70K | 1.40K | 1.50K | 1.60K |
| Total Other Revenue | 634.10K | 610.00K | 585.10K | 298.50K | 12.50K |
| Total Revenue | 1.32M | 957.70K | 586.60K | 300.10K | 14.20K |
| Cost of Revenue | 11.80K | 7.00K | 2.00K | 2.00K | 2.00K |
| Gross Profit | 1.31M | 950.80K | 584.60K | 298.10K | 12.20K |
| SG&A Expenses | 641.90K | 578.90K | 511.40K | 474.40K | 440.10K |
| Depreciation & Amortization | 51.80K | 56.50K | 61.00K | 137.40K | 216.00K |
| Other Operating Expenses | 880.40K | 910.60K | 936.30K | 911.80K | 892.90K |
| Total Operating Expenses | 1.59M | 1.56M | 1.52M | 1.56M | 1.61M |
| Operating Income | -274.80K | -602.70K | -931.70K | -1.26M | -1.60M |
| Income Before Tax | -290.00K | -614.00K | -938.90K | -1.71M | -2.50M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.29 | -0.61 | -0.94 | -1.71 | -2.50 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -290.00K | -614.00K | -938.90K | -1.71M | -2.50M |
| EBIT | -274.80K | -602.70K | -931.70K | -1.26M | -1.60M |
| EBITDA | -222.90K | -546.10K | -870.50K | -1.05M | -1.23M |
| EPS Basic | 0.00 | 0.00 | 0.00 | -0.01 | -0.01 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | -0.01 | -0.01 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 1.63B | 1.48B | 1.33B | 1.17B | 1.01B |
| Average Diluted Shares Outstanding | 1.63B | 1.48B | 1.33B | 1.17B | 1.01B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |